Al Razi Medical Company

Al Razi Medical Company is a Saudi Arabian pharmaceutical retailer operating in the healthcare sector. The company specializes in the retail sale of pharmaceutical products, including prescription and over-the-counter medicines, medical supplies, and health-related products. It serves customers through a network of retail pharmacies across Saudi Arabia, focusing on providing accessible healthcare solutions to the local population.

Al Razi generates revenue primarily from the sale of pharmaceutical products and medical supplies through its retail pharmacy chain. The company sources products from various pharmaceutical manufacturers and distributors, earning margins on retail sales. Its business model relies on a combination of product sales, with potential contributions from private-label or exclusive products. The recent strong revenue growth of 34% year-over-year indicates expanding operations or increased demand.

The company operates in the highly regulated pharmaceutical retail industry in Saudi Arabia, which is characterized by competition from other pharmacy chains, hospital pharmacies, and online platforms. Al Razi's positioning is as a regional player with a focus on the Saudi market. Its valuation metrics, such as a high PE ratio of 54.78 and EV/EBITDA of 17.06, suggest the market expects continued growth, but its low profit margin of 1.10% highlights the competitive and cost-intensive nature of the industry.

Al Razi's target audience includes individual consumers seeking prescription medications, over-the-counter drugs, and health products. Its main geographic market is Saudi Arabia, where it operates its pharmacy network. The company likely serves both walk-in customers and potentially institutional clients such as hospitals or clinics. With a market cap of 44.11 million SAR, it is a small-cap company focused on the domestic retail pharmacy segment.

An auto-generated descriptive profile based on company data, for informational purposes only.